Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1962 1
1964 4
1965 2
1966 1
1968 2
1969 3
1970 2
1971 1
1973 8
1974 5
1975 4
1976 5
1977 8
1978 11
1979 5
1980 6
1981 8
1982 10
1983 5
1984 7
1985 6
1986 6
1987 15
1988 13
1989 16
1990 14
1991 18
1992 11
1993 17
1994 23
1995 33
1996 22
1997 18
1998 36
1999 34
2000 40
2001 44
2002 49
2003 23
2004 18
2005 22
2006 26
2007 14
2008 14
2009 21
2010 28
2011 23
2012 25
2013 24
2014 25
2015 17
2016 27
2017 31
2018 20
2019 20
2020 34
2021 46
2022 41
2023 29
2024 30
2025 20

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,026 results

Results by year

Filters applied: . Clear all
Page 1
Virological characteristics of the SARS-CoV-2 NB.1.8.1 variant.
Uriu K, Okumura K, Uwamino Y, Chen L, Tolentino JE, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Ito J, Sato K; Genotype to Phenotype Japan (G2P-Japan) Consortium. Uriu K, et al. Among authors: asakura h. Lancet Infect Dis. 2025 Aug;25(8):e443. doi: 10.1016/S1473-3099(25)00356-1. Epub 2025 Jun 7. Lancet Infect Dis. 2025. PMID: 40489985 No abstract available.
[Overview].
Asakura H. Asakura H. Rinsho Ketsueki. 2022;63(5):440. doi: 10.11406/rinketsu.63.440. Rinsho Ketsueki. 2022. PMID: 35662169 Japanese. No abstract available.
Clinical practice guidelines for management of disseminated intravascular coagulation in Japan 2024. Part 1: sepsis.
Yamakawa K, Okamoto K, Seki Y, Ikezoe T, Ito T, Iba T, Gando S, Ushio N, Totoki T, Wada T, Asakura H, Ishikura H, Uchiba M, Uchiyama T, Kawasaki K, Kawano N, Kushimoto S, Koga S, Sakamoto Y, Tamura T, Nishio K, Hayakawa M, Matsumoto T, Madoiwa S, Mayumi T, Yamada S, Wada H; Committee of the Clinical Practice Guidelines for Management of Disseminated Intravascular Coagulation 2024, the Japanese Society on Thrombosis and Hemostasis. Yamakawa K, et al. Among authors: asakura h. Int J Hematol. 2025 May;121(5):592-604. doi: 10.1007/s12185-024-03896-9. Epub 2024 Dec 16. Int J Hematol. 2025. PMID: 39676120 Review.
Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike.
Yamasoba D, Kimura I, Nasser H, Morioka Y, Nao N, Ito J, Uriu K, Tsuda M, Zahradnik J, Shirakawa K, Suzuki R, Kishimoto M, Kosugi Y, Kobiyama K, Hara T, Toyoda M, Tanaka YL, Butlertanaka EP, Shimizu R, Ito H, Wang L, Oda Y, Orba Y, Sasaki M, Nagata K, Yoshimatsu K, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Kuramochi J, Seki M, Fujiki R, Kaneda A, Shimada T, Nakada TA, Sakao S, Suzuki T, Ueno T, Takaori-Kondo A, Ishii KJ, Schreiber G; Genotype to Phenotype Japan (G2P-Japan) Consortium; Sawa H, Saito A, Irie T, Tanaka S, Matsuno K, Fukuhara T, Ikeda T, Sato K. Yamasoba D, et al. Among authors: asakura h. Cell. 2022 Jun 9;185(12):2103-2115.e19. doi: 10.1016/j.cell.2022.04.035. Epub 2022 May 2. Cell. 2022. PMID: 35568035 Free PMC article.
Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant.
Suzuki R, Yamasoba D, Kimura I, Wang L, Kishimoto M, Ito J, Morioka Y, Nao N, Nasser H, Uriu K, Kosugi Y, Tsuda M, Orba Y, Sasaki M, Shimizu R, Kawabata R, Yoshimatsu K, Asakura H, Nagashima M, Sadamasu K, Yoshimura K; Genotype to Phenotype Japan (G2P-Japan) Consortium; Sawa H, Ikeda T, Irie T, Matsuno K, Tanaka S, Fukuhara T, Sato K. Suzuki R, et al. Among authors: asakura h. Nature. 2022 Mar;603(7902):700-705. doi: 10.1038/s41586-022-04462-1. Epub 2022 Feb 1. Nature. 2022. PMID: 35104835 Free PMC article.
Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5.
Kimura I, Yamasoba D, Tamura T, Nao N, Suzuki T, Oda Y, Mitoma S, Ito J, Nasser H, Zahradnik J, Uriu K, Fujita S, Kosugi Y, Wang L, Tsuda M, Kishimoto M, Ito H, Suzuki R, Shimizu R, Begum MM, Yoshimatsu K, Kimura KT, Sasaki J, Sasaki-Tabata K, Yamamoto Y, Nagamoto T, Kanamune J, Kobiyama K, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Shirakawa K, Takaori-Kondo A, Kuramochi J, Schreiber G, Ishii KJ; Genotype to Phenotype Japan (G2P-Japan) Consortium; Hashiguchi T, Ikeda T, Saito A, Fukuhara T, Tanaka S, Matsuno K, Sato K. Kimura I, et al. Among authors: asakura h. Cell. 2022 Oct 13;185(21):3992-4007.e16. doi: 10.1016/j.cell.2022.09.018. Epub 2022 Sep 14. Cell. 2022. PMID: 36198317 Free PMC article.
Virological characteristics of the SARS-CoV-2 XEC variant.
Kaku Y, Okumura K, Kawakubo S, Uriu K, Chen L, Kosugi Y, Uwamino Y, Begum MM, Leong S, Ikeda T, Sadamasu K, Asakura H, Nagashima M, Yoshimura K; Genotype to Phenotype Japan (G2P-Japan) Consortium; Ito J, Sato K. Kaku Y, et al. Among authors: asakura h. Lancet Infect Dis. 2024 Dec;24(12):e736. doi: 10.1016/S1473-3099(24)00731-X. Epub 2024 Nov 6. Lancet Infect Dis. 2024. PMID: 39521009 No abstract available.
Virological characteristics of the SARS-CoV-2 BA.2.86 variant.
Tamura T, Mizuma K, Nasser H, Deguchi S, Padilla-Blanco M, Oda Y, Uriu K, Tolentino JEM, Tsujino S, Suzuki R, Kojima I, Nao N, Shimizu R, Wang L, Tsuda M, Jonathan M, Kosugi Y, Guo Z, Hinay AA Jr, Putri O, Kim Y, Tanaka YL, Asakura H, Nagashima M, Sadamasu K, Yoshimura K; Genotype to Phenotype Japan (G2P-Japan) Consortium; Saito A, Ito J, Irie T, Tanaka S, Zahradnik J, Ikeda T, Takayama K, Matsuno K, Fukuhara T, Sato K. Tamura T, et al. Among authors: asakura h. Cell Host Microbe. 2024 Feb 14;32(2):170-180.e12. doi: 10.1016/j.chom.2024.01.001. Epub 2024 Jan 26. Cell Host Microbe. 2024. PMID: 38280382 Free article.
1,026 results